In this task, we defined a biomarker as “gene, protein or biological molecule identified in or associated with patient’s/model’s tumor.” Thus, biomarker entities can be mentioned using their full names (eg, epidermal growth factor receptor, lnc-RP11-536 K7.3, echinoderm microtubule-associated protein-like 4), standardized gene or protein symbols (NPM1, KRAS, PTEN) or abbreviations of metabolites (NADPH, D2HG). The gene discussed is KRAS; the disease is neoplasm.